Pharma has much to gain from leveraging components of a virtual business model, especially as an innovative way to work with experts and partners at the right moments throughout the product lifecycle.

I write about business model strategy and execution across healthcare. Pharmaceutical executives are waking up to a hard new reality. The winds of healthcare economic change, accelerated by a ...

I write about business model strategy and execution across healthcare. The pharmaceutical industry is in the midst of profound transformation. Downward economic pressures, a tightening federal ...

Datar, Srikant M., Carin-Isabel Knoop, and Cate Reavis. "Novartis Pharma: The Business Unit Model." Harvard Business School Case 101-030, January 2001. (Revised May 2003.) ...

Causal AI for predicting clinical efficacy is currently transforming the pharma business model. The gold standard for establishing causality is the prospective, randomized, placebo-controlled ...

As digital health becomes a commoditised product, pharma is evolving from being a product based industry toward one that is one rooted in solutions. Business model disruption in pharma is now a ...

At the start of each of the last five years, the share price of Alkermes has increased. It’s the kind of steady trajectory ...

NDAQ:ASND) Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference ...

Ascendis Pharma’s President and Chief Executive Officer. “Our expanding TransCon technology platform and partnerships demonstrate that our business model built on fast, successful drug ...